Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1995-10-19
|
pubmed:abstractText |
Murine NK cells are known to mediate F1-hybrid anti-parental graft rejection responses. This phenomenon has been linked to the MHC, and in particular, to the alpha 1/alpha 2 domains of the MHC class I molecules. Here, we have addressed the role of MHC class I bound peptides in NK cell mediated F1-hybrid anti-parental rejection by studying the resistance of F1-hybrids between B6 and different bm mutant strains to B6-derived RBL-5 lymphoma cell line. Tumor development occurred at a similar frequency in all combinations of (B6 x bm)F1 mice and control B6 mice. These results suggest that absence of a specific MHC class I presented peptide repertoire on grafted cells is not sufficient to induce NK cell mediated F1-hybrid anti-parental rejection responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0161-5890
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
789-94
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7675041-Animals,
pubmed-meshheading:7675041-Antigen Presentation,
pubmed-meshheading:7675041-Cell Transplantation,
pubmed-meshheading:7675041-Cells, Cultured,
pubmed-meshheading:7675041-Computer Simulation,
pubmed-meshheading:7675041-Graft Rejection,
pubmed-meshheading:7675041-Histocompatibility Antigens Class I,
pubmed-meshheading:7675041-Immunity, Cellular,
pubmed-meshheading:7675041-Killer Cells, Natural,
pubmed-meshheading:7675041-Mice,
pubmed-meshheading:7675041-Mice, Inbred BALB C,
pubmed-meshheading:7675041-Mice, Inbred C57BL,
pubmed-meshheading:7675041-Mice, Mutant Strains,
pubmed-meshheading:7675041-Mutagenesis, Site-Directed
|
pubmed:year |
1995
|
pubmed:articleTitle |
Altered MHC class I presented peptide repertoire is not sufficient to induce NK cell mediated F1-hybrid resistance.
|
pubmed:affiliation |
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|